文献速递临床试验与 GCP真实世界研究与卫生经济

预防性泡沫敷料预防高危住院患者骶尾部压力性损伤的有效性:EEPOC试验

EffEctiveness of Prophylactic fOam dressings in the prevention of saCral pressure injuries in at-risk hospitalised patients: the EEPOC trial.
PubMed 文献 · Trials · 2023-01-31

EEPOC是一项在澳大利亚三家医院开展的多中心、实用性、平行组随机对照试验,计划样本量1320例,旨在评估预防性硅胶泡沫边框敷料在内外科住院患者中预防骶尾部压力性损伤的临床与成本效果。主要结局为骶尾部压力性损伤的累积发生率,由盲法独立评估者通过去标识化数字修饰骶尾部照片每日评估至14天。试验于2020年3月5日启动,因COVID-19显著延迟。

要点

  • 多中心随机对照试验评估预防性硅胶泡沫敷料预防骶尾部压力性损伤。
  • 计划样本量1320例,把握度>90%检测主要结局5%差异,α=0.05。
  • 主要结局由盲法独立评估者依据去标识化数字修饰骶尾部照片每日评估至14天。

核心结论

  • 该试验旨在提供预防性敷料对内外科患者医院获得性骶尾部压力性损伤发生影响的确定性证据。

研究设计与样本

  • 多中心、实用性、平行组随机对照试验,在澳大利亚三家医院的内外科病房招募成人患者。
  • 纳入标准:≥18岁、入院前36小时内、预计住院时间≥24小时、评估为医院获得性压力性损伤高风险。
  • 计划样本量1320例,把握度>90%检测主要结局5%差异,α=0.05。
  • 参与者通过独立于试验的网络随机化服务分配至预防性硅胶泡沫敷料组或无任何敷料的常规护理对照组。

主要发现

  • 主要结局为发生骶尾部压力性损伤患者的累积发生率。
  • 次要结局包括骶尾部压力性损伤发生时间、严重程度(分期)发生率、敷料成本效果及过程评估。
  • 发生骶尾部压力性损伤者额外随访14天以估算压力性损伤治疗成本。
  • 临床结局分析基于意向性治疗、符合方案集和敏感性分析。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 试验于2020年3月5日启动,因COVID-19显著延迟。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prophylactic dressings are increasingly used to prevent pressure injuries in hospitalised patients. However, evidence regarding the effectiveness of these dressings is still emerging. This trial aims to determine the clinical and cost-effectiveness of a prophylactic silicone foam border dressing in preventing sacral pressure injuries in medical-surgical patients. METHODS: This is a multicentre, pragmatic, parallel group, randomised controlled trial. A sample size of 1320 was calculated to have >90% power to detect a 5% difference in the primary outcome at an alpha of 0.05. Adult patients admitted to participating medical-surgical wards are screened for eligibility: ≥18 years, admitted to hospital within the previous 36 h, expected length of stay of ≥24 h, and assessed high risk for hospital-acquired pressure injury. Consenting participants are randomly allocated to either prophylactic silicone foam dressing intervention or usual care without any dressing as the control group via a web-based randomisation service independent of the trial. Patients are enrolled across three Australian hospitals. The primary outcome is the cumulative incidence of patients who develop a sacral pressure injury. Secondary outcomes include the time to sacral pressure injury, incidence of severity (stage) of sacral pressure injury, cost-effectiveness of dressings, and process evaluation. Participant outcomes are assessed daily for up to 14 days by blinded independent outcome assessors using de-identified, digitally modified sacral photographs. Those who develop a sacral pressure injury are followed for an additional 14 days to estimate costs of pressure injury treatment. Analysis of clinical outcomes will be based on intention-to-treat, per-protocol, and sensitivity analyses. DISCUSSION: This trial aims to provide definitive evidence on the effect prophylactic dressings have on the development of hospital-acquired sacral pressure injuries in medical-surgical patients. A parallel economic evaluation of pressure injury prevention and treatment will enable evidence-informed decisions and policy. The inclusion of a process evaluation will help to explain the contextual factors that may have a bearing on trial results including the acceptability of the dressings to patients and staff. The trial commenced 5 March 2020 and has been significantly delayed due to COVID-19. TRIAL REGISTRATION: ANZCTR ACTRN12619000763145. Prospectively registered on 22 May 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Walker RM, Chaboyer W, Cooke M, et al. EffEctiveness of Prophylactic fOam dressings in the prevention of saCral pressure injuries in at-risk hospitalised patients: the EEPOC trial. Trials. 2023. PMID: 36721259. doi:10.1186/s13063-022-06999-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。